Gsa Capital Partners LLP Palatin Technologies Inc Transaction History

Gsa Capital Partners LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$0.44 - $0.63 $482,456 - $690,789	-1,096,491 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$0.48 - $0.72 $498,336 - $747,504	1,038,201 Added 1781.1%	1,096,491 $669,000
Q1 2021 May 10, 2021	BUY	$0.68 - $1.25 $39,637 - $72,862	58,290 New	58,290 $40,000
Q4 2019 Feb 12, 2020	SELL	$0.75 - $0.89 $142,685 - $169,319	-190,247 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$0.78 - $1.09 $148,392 - $207,369	190,247 New	190,247 $173,000
Q1 2018 May 11, 2018	SELL	$0.84 - $1.18 $15,288 - $21,476	-18,200 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$0.68 - $1.0 $12,376 - $18,200	18,200	18,200 $16,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.27M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.